The study below was completed in 2016 (not by EX1) using human mesenchymal Stem Cell derived exosomes for wound healing in rats. There are other examples of similar studies completed around the world. The exosomes used in this study were not clinical grade and were by no means pure.
Exopharm will be doing a similar study using clinical grade exosomes (using LEAP technology) secreted from human blood platelets.
Awaiting the Exopharm animal study results this month.
